|
1
|
Adams MN, Ramachandran R, Yau MK, Suen JY,
Fairlie DP, Hollenberg MD and Hooper JD: Structure, function and
pathophysiology of protease activated receptors. Pharmacol Ther.
130:248–282. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ossovskaya VS and Bunnett NW:
Protease-activated receptors: contribution to physiology and
disease. Physiol Rev. 84:579–621. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Vergnolle N, Ferazzini M, D'Andrea MR,
Buddenkotte J and Steinhoff M: Proteinase-activated receptors:
novel signals for peripheral nerves. Trends Neurosci. 26:496–500.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Steinhoff M, Buddenkotte J, Shpacovitch V,
Rattenholl A, Moormann C, Vergnolle N, Luger TA and Hollenberg MD:
Proteinase-activated receptors: transducers of proteinase-mediated
signaling in inflammation and immune response. Endocr Rev. 26:1–43.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hamm HE: How activated receptors couple to
G proteins. Proc Natl Acad Sci USA. 98:4819–4821. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
De Candia E: Mechanisms of platelet
activation by thrombin: a short history. Thromb Res. 129:250–256.
2012. View Article : Google Scholar
|
|
7
|
Kawabata A: Gastrointestinal functions of
proteinase-activated receptors. Life Sci. 74:247–254. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Schmidlin F and Bunnett NW:
Protease-activated receptors: how proteases signal to cells. Curr
Opin Pharmacol. 1:575–582. 2001. View Article : Google Scholar
|
|
9
|
Yau MK, Liu L and Fairlie DP: Toward drugs
for protease-activated receptor 2 (PAR2). J Med Chem. 56:7477–7497.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ramachandran R, Noorbakhsh F, Defea K and
Hollenberg MD: Targeting proteinase-activated receptors:
therapeutic potential and challenges. Nat Rev Drug Discov.
11:69–86. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
11
|
Böhm SK, Grady EF and Bunnett NW:
Regulatory mechanisms that modulate signalling by G-protein-coupled
receptors. Biochem J. 322:1–18. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ishihara H, Connolly AJ, Zeng D, Kahn ML,
Zheng YW, Timmons C, Tram T and Coughlin SR: Protease-activated
receptor 3 is a second thrombin receptor in humans. Nature.
386:502–506. 1997. View
Article : Google Scholar : PubMed/NCBI
|
|
13
|
Xu WF, Andersen H, Whitmore TE, Presnell
SR, Yee DP, Ching A, Gilbert T, Davie EW and Foster DC: Cloning and
characterization of human protease-activated receptor 4. Proc Natl
Acad Sci USA. 95:6642–6646. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Gieseler F, Ungefroren H, Settmacher U,
Hollenberg MD and Kaufmann R: Proteinase-activated receptors (PARs)
- focus on receptor-receptor-interactions and their physiological
and pathophysiological impact. Cell Commun Signal. 11:862013.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Leger AJ, Covic L and Kuliopulos A:
Protease-activated receptors in cardiovascular diseases.
Circulation. 114:1070–1077. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Cirino G and Vergnolle N:
Proteinase-activated receptors (PARs): crossroads between innate
immunity and coagulation. Curr Opin Pharmacol. 6:428–434. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Vergnolle N: Protease-activated receptors
as drug targets in inflammation and pain. Pharmacol Ther.
123:292–309. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lee H and Hamilton JR: Physiology,
pharmacology, and therapeutic potential of protease-activated
receptors in vascular disease. Pharmacol Ther. 134:246–259. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Xu H, Echemendia N, Chen S and Lin F:
Identification and expression patterns of members of the
protease-activated receptor (PAR) gene family during zebrafish
development. Dev Dyn. 240:278–287. 2011. View Article : Google Scholar
|
|
20
|
Kahn ML, Hammes SR, Botka C and Coughlin
SR: Gene and locus structure and chromosomal localization of the
protease-activated receptor gene family. J Biol Chem.
273:23290–23296. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Tamura K, Peterson D, Peterson N, Stecher
G, Nei M and Kumar S: MEGA5: molecular evolutionary genetics
analysis using maximum likelihood, evolutionary distance, and
maximum parsimony methods. Mol Biol Evol. 28:2731–2739. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ronquist F and Huelsenbeck JP: MrBayes 3:
Bayesian phylogenetic inference under mixed models. Bioinformatics.
19:1572–1574. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Posada D: jModelTest: Phylogenetic model
averaging. Mol Biol Evol. 25:1253–1256. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Guindon S and Gascuel O: A simple, fast,
and accurate algorithm to estimate large phylogenies by maximum
likelihood. Syst Biol. 52:696–704. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yang Z: PAML 4: Phylogenetic analysis by
maximum likelihood. Mol Biol Evol. 24:1586–1591. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Yang Z, Nielsen R, Goldman N and Pedersen
AM: Codon-substitution models for heterogeneous selection pressure
at amino acid sites. Genetics. 155:431–449. 2000.PubMed/NCBI
|
|
27
|
Gu X and Vander Velden K: DIVERGE:
phylogeny-based analysis for functional-structural divergence of a
protein family. Bioinformatics. 18:500–501. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Gu X: Statistical methods for testing
functional divergence after gene duplication. Mol Biol Evol.
16:1664–1674. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Piontkivska H and Nei M: Birth-and-death
evolution in primate MHC class I genes: divergence time estimates.
Mol Biol Evol. 20:601–609. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Hirano K: The roles of
proteinase-activated receptors in the vascular physiology and
pathophysiology. Arterioscler Thromb Vasc Biol. 27:27–36. 2007.
View Article : Google Scholar
|
|
31
|
Weiss EJ, Hamilton JR, Lease KE and
Coughlin SR: Protection against thrombosis in mice lacking PAR3.
Blood. 100:3240–3244. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Yue R, Li H, Liu H, Li Y, Wei B, Gao G,
Jin Y, Liu T, Wei L, Du J and Pei G: Thrombin receptor regulates
hematopoiesis and endothelial-to-hematopoietic transition. Dev
Cell. 22:1092–1100. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Guo H, Liu D, Gelbard H, Cheng T, Insalaco
R, Fernández JA, Griffin JH and Zlokovic BV: Activated protein C
prevents neuronal apoptosis via protease activated receptors 1 and
3. Neuron. 41:563–572. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Busso N, Chobaz-Péclat V, Hamilton J, Spee
P, Wagtmann N and So A: Essential role of platelet activation via
protease activated receptor 4 in tissue factor-initiated
inflammation. Arthritis Res Ther. 10:R422008. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Augé C, Balz-Hara D, Steinhoff M,
Vergnolle N and Cenac N: Protease-activated receptor-4 (PAR 4): a
role as inhibitor of visceral pain and hypersensitivity.
Neurogastroenterol Motil. 21:1189–e107. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Coughlin SR: Thrombin signalling and
protease-activated receptors. Nature. 407:258–264. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Lin H, Liu AP, Smith TH and Trejo J:
Cofactoring and dimerization of proteinase-activated receptors.
Pharmacol Rev. 65:1198–1213. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Rothmeier AS and Ruf W: Protease-activated
receptor 2 signaling in inflammation. Semin Immunopathol.
34:133–149. 2012. View Article : Google Scholar
|
|
39
|
Hirano K and Kanaide H: Role of
protease-activated receptors in the vascular system. J Atheroscler
Thromb. 10:211–225. 2003. View Article : Google Scholar : PubMed/NCBI
|
